| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b65747ed78f05dd9ebe107b50ce2855
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_543c6c65952993acf92ccbb172d070c4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-655
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6552
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H13-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-665
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H13-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-655
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7024 |
| filingDate |
1989-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e49eea1a488e25f8d8639e24f6fc07e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19c51f53245df0c132ce8cea2326e0eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c391973398adaf625e4d5395e4667e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19a0337c54adac04f7f559407cf8ef02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8b8d6b2f4aa64b2885a74ad55d1303c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f08da2e9d56d67caa5f074c18b4fc12 |
| publicationDate |
1991-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H03106894-A |
| titleOfInvention |
Lipid a monosaccharide analog |
| abstract |
NEW MATERIAL:A lipid A monosaccharide analog expressed by formula I (R 1 is H or OH; l is integer of 8-14; m is integer of 11-17; n is integer of 8-14). n EXAMPLE: 1,5-Anhydro-2-deoxy-2-[(3R)-3-hydroxytetradecanamide]-4-O- phosphono-3-O-[(3RS)-3-undecylheptadecanoyl]-D-glucitol. n USE: An immunoactivating agent and antitumor agent. n PREPARATION: For example, a compound expressed by formula II (R' 1 is H or trimethylsilylethoxy) derived from D-glucosamine, etc., is reacted with a fatty acid replaced with [2-(trimethylsilyl)-ethoxymethoxy] group and then protecting groups other than protecting group at the 3-position are removed and then OH group at the 3-position and OH group at the 6-position are successively protected and OH group at the 5-position is phospholylated and then protecting at 6-position is removed and further, the resultant compound is hydrogenated to provide the compound expressed by formula I. n COPYRIGHT: (C)1991,JPO&Japio |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9311139-A1 |
| priorityDate |
1989-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |